An Open-label, Randomized, Crossover Study to Evaluate the Pharmacokinetics and Safety of a Fixed Dose Combination of Raloxifen/Cholecalciferol Compared With Coadministration of Raloxifen and Cholecalciferol in Healthy Male Subjects

Trial Profile

An Open-label, Randomized, Crossover Study to Evaluate the Pharmacokinetics and Safety of a Fixed Dose Combination of Raloxifen/Cholecalciferol Compared With Coadministration of Raloxifen and Cholecalciferol in Healthy Male Subjects

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 17 Jan 2017

At a glance

  • Drugs Colecalciferol/raloxifene (Primary) ; Colecalciferol; Raloxifene
  • Indications Breast cancer; Fracture; Postmenopausal osteoporosis; Vitamin D deficiency
  • Focus Pharmacokinetics
  • Sponsors Alvogen Korea
  • Most Recent Events

    • 17 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top